The Impact of Dupilumab Treatment on Anxiety and Depression Symptoms in Patients With Moderate-to-Severe Atopic Dermatitis

This study is examining whether dupilumab — a medication injected under the skin to treat moderate-to-severe eczema (atopic dermatitis) — also helps reduce anxiety and depression symptoms that many eczema patients experience. **You may be eligible if...** - You have moderate to severe eczema (atopic dermatitis) - You also have symptoms of anxiety and/or depression - Your doctor has already decided to start you on dupilumab treatment (within 30 days of joining the study) **You may NOT be eligible if...** - You are pregnant, breastfeeding, or planning to become pregnant in the next 6 months - You are currently in another clinical trial - You have an active infection that requires systemic treatment - You have HIV, active hepatitis B or C, or cancer - You have taken antidepressants or anti-anxiety medication within the past 6 months, or plan to during the study Talk to your doctor to see if this trial is right for you.